These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 3534039)

  • 1. Fibronectin and the critically ill patient: current status.
    Saba TM; Kiener JL; Holman JM
    Intensive Care Med; 1986; 12(5):350-8. PubMed ID: 3534039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of fibronectin and opsonic deficiency in patients. A controlled study.
    Saba TM; Blumenstock FA; Shah DM; Kaplan JE; Cho E; Scovill W; Stratton H; Newell J; Gottlieb M; Sedransk N
    Ann Surg; 1984 Jan; 199(1):87-96. PubMed ID: 6362585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma fibronectin and the critically ill.
    Czop JK
    Intensive Care Med; 1986; 12(5):337-9. PubMed ID: 3771913
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma fibronectin and fibronectin therapy in sepsis and critical illness.
    Grossman JE
    Rev Infect Dis; 1987; 9 Suppl 4():S420-30. PubMed ID: 3326138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical use of fibronectin. (Potential applications).
    Mosher DF; Grossman JE
    Ric Clin Lab; 1983; 13(1):43-54. PubMed ID: 6407090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma fibronectin.
    Saba TM
    Br J Hosp Med; 1986 Nov; 36(5):364, 366. PubMed ID: 3790862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryoprecipitate infusion fails to improve organ function in septic shock.
    Hesselvik F; Brodin B; Carlsson C; Cedergren B; Jorfeldt L; Liedén G
    Crit Care Med; 1987 May; 15(5):475-83. PubMed ID: 3552444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of opsonic deficiency in surgical, trauma, and burn patients by infusion of purified human plasma fibronectin. Correlation with experimental observations.
    Saba TM; Blumenstock FA; Shah DM; Landaburu RH; Hrinda ME; Deno DC; Holman JM; Cho E; Dayton C; Cardarelli PM
    Am J Med; 1986 Feb; 80(2):229-40. PubMed ID: 3946437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung vascular permeability after reversal of fibronectin deficiency in septic sheep. Correlation with patient studies.
    Saba TM; Niehaus GD; Scovill WA; Blumenstock FA; Newell JC; Holman J; Powers SR
    Ann Surg; 1983 Nov; 198(5):654-62. PubMed ID: 6416192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Review. The intensive medical care relevance of plasma fibronectin].
    Lundsgaard-Hansen P; Doran JE; Rubli E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(4):435-45. PubMed ID: 2431963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma fibronectin level in erysipelas.
    Massoud MM; Mahmoud BA; Gadballa MR
    J Egypt Public Health Assoc; 1990; 65(5-6):601-7. PubMed ID: 2134094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma fibronectin: relevance for anesthesiology and intensive care.
    Doran JE; Lundsgaard-Hansen P; Rubli E
    Intensive Care Med; 1986; 12(5):340-9. PubMed ID: 3534038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of fibronectin-rich human cryoprecipitate on fluid volume requirements in sheep during postoperative sepsis.
    Holman JM; Saba TM; Lewis E
    J Trauma; 1988 May; 28(5):571-81. PubMed ID: 3130490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal of plasma fibronectin deficiency in septic-injured patients by cryoprecipitate infusion.
    Saba TM
    Prog Clin Biol Res; 1982; 108():129-50. PubMed ID: 6757957
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical use of fibronectin in critically ill patients.
    Grossman JE
    Prog Clin Biol Res; 1989; 299():157-67. PubMed ID: 2657787
    [No Abstract]   [Full Text] [Related]  

  • 16. Current status of fibronectin in transfusion medicine: focus on clinical studies.
    Powell FS; Doran JE
    Vox Sang; 1991; 60(4):193-202. PubMed ID: 1926827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of surgery for obstructive jaundice is not associated with reduced levels of plasma fibronectin.
    Hadjis NS; Griffin S; Blumgart LH; Knox P
    Clin Sci (Lond); 1986 Jan; 70(1):73-9. PubMed ID: 3943280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic administration of fibronectin: current uses and potential applications.
    Yoder MC
    Clin Perinatol; 1991 Jun; 18(2):325-41. PubMed ID: 1879111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a rapid immunoturbidimetric assay for opsonic fibronectin in surgical and trauma patients.
    Saba TM; Albert WH; Blumenstock FA; Evanega G; Staehler F; Cho E
    J Lab Clin Med; 1981 Oct; 98(4):482-91. PubMed ID: 7288265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibronectin: applications to clinical medicine.
    Snyder EL; Luban NL
    Crit Rev Clin Lab Sci; 1986; 23(1):15-34. PubMed ID: 3512168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.